VIRIDIAN THERAPEUTICS INC (VRDN) Stock Earnings & Estimates
NASDAQ:VRDN - US92790C1045 - Common Stock
18.56 USD
-0.1 (-0.54%)
18.7 USD
+0.14 (+0.75%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.77M -40.20% | 314K -82.26% | 302K -3.82% | 145.095K -51.96% | 51.063M 35,092.80% | 291.79M 471.43% | 671.17M 130.02% | 1.023B 52.42% | 1.398B 36.66% | 1.709B 22.25% | 1.829B 7.02% | |
| EBITDA YoY % growth | -134.04M -68.37% | -253.928M -89.44% | -298.495M -17.55% | -336.441M -12.71% | -323.33M 3.90% | -179.175M 44.58% | 625.9M 449.32% | 837.83M 33.86% | 1.1B 31.29% | 1.335B 21.36% | 1.363B 2.10% | |
| EBIT YoY % growth | -134.3M -68.44% | -254.45M -89.46% | -299.035M -17.52% | -385.831M -29.03% | -388.376M -0.66% | -237.891M 38.75% | 102.22M 142.97% | 386.74M 278.34% | 650.97M 68.32% | 914.77M 40.52% | 1.014B 10.85% | |
| Operating Margin | -7,587.57% | -81,035.03% | -99,018.21% | -265,916.13% | -760.58% | -81.53% | 15.23% | 37.80% | 46.56% | 53.53% | 55.44% | |
| EPS YoY % growth | -4.03 47.59% | -5.32 -32.01% | -3.96 25.56% | -3.90 1.54% | -4.21 -8.08% | -1.92 54.41% | 0.18 109.56% | 2.86 1,459.28% | 4.72 64.75% | 6.24 32.21% | 6.86 10.09% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.90 21.45% | -1.05 -4.59% | -1.12 -28.97% | -1.18 -17.71% | -1.12 -23.53% | -1.25 -19.56% |
| Revenue Q2Q % growth | 50.408K -41.39% | 44.452K -38.26% | 51K -29.17% | 51K -32.00% | 7.191M 14,165.48% | 21.545M 48,368.45% |
| EBITDA Q2Q % growth | -8.923M 89.26% | -81.027M 6.79% | -82.732M 11.75% | -85.436M 19.81% | -91.167M -921.71% | -68.996M 14.85% |
| EBIT Q2Q % growth | -82.98M 0.60% | -107.353M -22.73% | -101.06M -7.66% | -107.017M -0.23% | -106.861M -28.78% | -99.105M 7.68% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.00 1.96% | -1.03 | 0.03 | 2.88% |
| Q1 2025 Q2Q % growth | -0.87 -10.13% | -0.99 | 0.12 | 11.80% |
| Q4 2024 Q2Q % growth | -1.00 25.93% | -1.06 | 0.06 | 5.31% |
| Q3 2024 Q2Q % growth | -1.15 -5.50% | -1.08 | -0.07 | -6.60% |
| Q2 2024 Q2Q % growth | -1.02 19.69% | -0.91 | -0.11 | -12.54% |
| Q1 2024 Q2Q % growth | -0.79 50.93% | -1.13 | 0.34 | 29.83% |
| Q4 2023 Q2Q % growth | -1.35 -19.47% | -1.02 | -0.33 | -31.95% |
| Q3 2023 Q2Q % growth | -1.09 -26.74% | -1.29 | 0.20 | 15.60% |
| Q2 2023 Q2Q % growth | -1.27 -19.81% | -1.32 | 0.05 | 3.82% |
| Q1 2023 Q2Q % growth | -1.61 -64.29% | -1.04 | -0.57 | -54.81% |
| Q4 2022 Q2Q % growth | -1.13 14.39% | -0.74 | -0.39 | -52.18% |
| Q3 2022 Q2Q % growth | -0.86 31.20% | -1.04 | 0.18 | 17.11% |
| Q2 2022 Q2Q % growth | -1.06 52.04% | -0.92 | -0.14 | -14.92% |
| Q1 2022 Q2Q % growth | -0.98 66.32% | -1.10 | 0.12 | 10.71% |
| Q4 2021 Q2Q % growth | -1.32 75.14% | -0.92 | -0.40 | -44.25% |
| Q3 2021 Q2Q % growth | -1.25 16.67% | -1.50 | 0.25 | 16.82% |
| Q2 2021 Q2Q % growth | -2.21 -22.78% | -1.55 | -0.66 | -42.73% |
| Q1 2021 Q2Q % growth | -2.91 -7.78% | -0.77 | -2.14 | -277.37% |
| Q4 2020 Q2Q % growth | -5.31 -14.19% | -0.63 | -4.68 | -748.79% |
| Q3 2020 Q2Q % growth | -1.50 72.22% | -2.03 | 0.53 | 26.01% |
| Q2 2020 Q2Q % growth | -1.80 58.62% | -2.52 | 0.72 | 28.70% |
| Q1 2020 Q2Q % growth | -2.70 52.63% | -2.94 | 0.24 | 8.09% |
| Q4 2019 Q2Q % growth | -4.65 | -3.86 | -0.79 | -20.60% |
| Q3 2019 Q2Q % growth | -5.40 | -4.53 | -0.87 | -19.24% |
| Q2 2019 Q2Q % growth | -4.35 | -5.70 | 1.35 | 23.67% |
| Q1 2019 Q2Q % growth | -5.70 | -5.26 | -0.44 | -8.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 75K 4.17% | 44.513K | 30.487K | 68.49% |
| Q1 2025 Q2Q % growth | 72K | 71.533K | 467.3999999999942 | 0.65% |
| Q4 2024 Q2Q % growth | 72K | 45.39K | 26.61K | 58.63% |
| Q3 2024 Q2Q % growth | 86K 19.44% | 46.685K | 39.315K | 84.21% |
| Q2 2024 Q2Q % growth | 72K | 87.873K | -15.873K | -18.06% |
| Q1 2024 Q2Q % growth | 72K -26.53% | 72.604K | -603.6000000000058 | -0.83% |
| Q4 2023 Q2Q % growth | 72K -34.55% | 162.792K | -90.792K | -55.77% |
| Q3 2023 Q2Q % growth | 72K -94.00% | 112.853K | -40.853K | -36.20% |
| Q2 2023 Q2Q % growth | 72K -72.31% | 220.493K | -148.493K | -67.35% |
| Q1 2023 Q2Q % growth | 98K -55.45% | 113.444K | -15.444K | -13.61% |
| Q4 2022 Q2Q % growth | 110K -47.62% | 522.118K | -412.118K | -78.93% |
| Q3 2022 Q2Q % growth | 1.2M 471.43% | 315.517K | 884.483K | 280.33% |
| Q2 2022 Q2Q % growth | 260K -76.15% | 236.344K | 23.656K | 10.01% |
| Q1 2022 Q2Q % growth | 220K -84.83% | 310.284K | -90.284K | -29.10% |
| Q4 2021 Q2Q % growth | 210K 320.00% | 291.383K | -81.383K | -27.93% |
| Q3 2021 Q2Q % growth | 210K | 463.284K | -253.284K | -54.67% |
| Q2 2021 Q2Q % growth | 1.09M 541.18% | 1.09M | % | |
| Q1 2021 Q2Q % growth | 1.45M 74.70% | 1.45M | % | |
| Q4 2020 Q2Q % growth | 50K -94.32% | 81.6K | -31.6K | -38.73% |
| Q3 2020 Q2Q % growth | -100.00% | 157.59K | -157.59K | -100.00% |
| Q2 2020 Q2Q % growth | 170K -93.23% | 532.236K | -362.236K | -68.06% |
| Q1 2020 Q2Q % growth | 830K 124.32% | 594.15K | 235.85K | 39.70% |
| Q4 2019 Q2Q % growth | 880K | 737.256K | 142.744K | 19.36% |
| Q3 2019 Q2Q % growth | 700K | 1.186M | -486K | -40.98% |
| Q2 2019 Q2Q % growth | 2.51M | 262.477K | 2.248M | 856.28% |
| Q1 2019 Q2Q % growth | 370K | 471.75K | -101.75K | -21.57% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 12.44% | 18.38% | 3.29% | 3.49% |
| Revenue | 13.24% | -25.87% | -28.29% | -22.08% |